Education
Academic Background-
Ph.D. University of Novi Sad, Serbia Medical Science | Completed: 1986
Publications (114)
Selected Scholarly Contributions
Pharmacogenetic biomarkers as tools for pharmacoepidemiology of severe adverse drug reactions 2013.
Momir Mikov
2013
The bile acid membrane receptor TGR5: A novel pharmacological target in metabolic, inflammatory and neoplastic disorders.
Momir Mikov
2013
The influence of intestinal tract and probiotics on the fate of orally administered drugs.
Momir Mikov
2013
Effect of simultaneous exposure to benzene and ethanol on urinary thioether excretion.
Momir Mikov
2012
Ethical and legal aspects of oncogenomics.
Momir Mikov
2012
The impact of farnesoid X receptor activation on intestinal permeability in inflammatory bowel disease.
Momir Mikov
2012
Probiotics-interactions with bile acids and impact on cholesterol metabolism.
Momir Mikov
2012
An insight on differences in availability and reimbursement of orphan medicines among Serbia, Bulgaria and Sweden.
Momir Mikov
2012
Pleiotropic functions of bile acids mediated by the farnesoid X receptor.
Momir Mikov
2012
Tacrolimus as a part of immunosuppressive treatment in kidney transplantation patients: Sex differences.
Momir Mikov
2012
Hypoglicemic effect of herbicide 2,4-dichlorophenoxyacetic acid (2,4-D).
Momir Mikov
2011
Biotransformation of L-selenomethionine and selenite in rat gut contents.
Momir Mikov
2011
Consumption of serum lipid-reducing drugs in Serbia compared with Scandinavian countries: A population-based study, 2004-2008.
Momir Mikov
2011
Effect of sodium salt of ,3alpha, 12alpha-dihydroxy-7-oxo-5beta-cholanoic and 3,7,12-trioxo-5beta-cholanoic acid on verapamile hydrochloride in biophysical-chemical model experiments.
Momir Mikov
2011
Hypoglycaemic action of stevioside and а barley and brewer's yeast based preparation in the experimental model on mice.
Momir Mikov
2011
Comparison of dissolution profiles and serum concentrations of two lamotrigine tablet formulations.
Momir Mikov
2011
Gender differences in pharmacokinetics of tacrolimus and their clinical significance in kidney transplant recipients.
Momir Mikov
2011
2011
Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats.
Momir Mikov
2011
The protective effects of silymarin against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats.
Momir Mikov
2011
[Effect of chromium enriched fermentation product of barley and brewer's yeast and its combination with rosiglitazone on experimentally induced hyperglycaemia in mice].
Momir Mikov
2011
The influence of probiotics on the cervical malignancy diagnostics quality.
Momir Mikov
2011
Clinical pharmacokinetics of tacrolimus after the first oral administration in renal transplant recipients on triple immunosuppressive therapy.
Momir Mikov
2010
Effect of bile salts on the transport of morphine-6-glucuronide in rat brain endothelial cells.
Momir Mikov
2010
Influence of bile acid derivates on tramadol analgesic effect in mice.
Momir Mikov
2010
Physicochemical and biological characterization of monoketocholic acid, a novel permeability enhancer.
Momir Mikov
2009
Gliclazide reduces MKC intestinal transport in healthy but not in diabetic rats.
Momir Mikov
2009
Cefotaxime pharmacokinetics after oral application in the form of 3alpha,7alfa-dihydroxy-12-oxo-5beta-cholanate micro vesicules in rat.
Momir Mikov
2009
Monoketocholate can decrease transcellular permeation of methotrexate across Caco-2 cell monolazers and reduce its intestinal absorption in rat.
Momir Mikov
2009
Protective effects of celery juice in treatments with doxorubicin.
Momir Mikov
2009
An improved HPLC method for the investigation of L-selenomethionine metabolism in rat gut contents.
Momir Mikov
2009
Cefotaxime pharmacokinetics after oral application in the form of 3alpha,7alpha-dihydroxy-12-keto-5beta-cholanate microvesicles in rat.
Momir Mikov
2009
Simultaneous determination of methotrexate and its polyglutamate metabolites in Caco-2 cells by liquid chromatography-tandem mass spectrometry.
Momir Mikov
2009
Monoketocholate can decrease transcellular permeation of methotrexate across Caco-2 cell monolayers and reduce its intestinal absorption in rat.
Momir Mikov
2009
Effect of 12-monoketocholic acid on modulation of analgesic action of morphine and tramadol.
Momir Mikov
2009
Evaluation of statistical power function for various diclofenac bioequivalence trials with different subject numbers.
Momir Mikov
2009
Lamotrigine and valproate pharmacokinetics interactions in epileptic patients.
Momir Mikov
2009
Critical micellar concentrations of keto derivatives of selected bile acids: Thermodynamic functions of micelle formation.
Momir Mikov
2008
Effect of stevioside and sodium salt of monoketocholic acid on glycemia in normoglycemic and diabetic rats.
Momir Mikov
2008
Influence of the semisynthetic bile acid MKC on the ileal permeation of gliclazide in vitro in healthy and diabetic rats treated with probiotics.
Momir Mikov
2008
Probiotic treatment proceeded by a single dose of bile acid and gliclazide exert the most hypoglycemic effect in type 1 diabetic rats.
Momir Mikov
2008
The influence of 3 alpha,7 alpha-dihydroxy-12-keto-5 beta-cholanate on gliclazide pharmacokinetics and glucose levels in a rat model of diabetes.
Momir Mikov
2008
2008
Probiotic pre‐treatment reduces gliclazide permeation (ex vivo) in healthy rats but increases it in diabetic rats to the level seen in untreated healthy rats.
Momir Mikov
2008
Influence of sodium monoketocholate on the hypolipidemic activity of lovastatin in healthy and diabetic rats.
Momir Mikov
2008
Role of gut microflora in drug metabolism-pets or pests.
Momir Mikov
2007
Bile Acids: A bitter sweat remedy for diabetes.
Momir Mikov
2007
Bioavailability and hypoglycemic activity of the semisynthetic bile acid salt, sodium 3alpha,7alpha-dihydroxy-12-oxo-5beta-cholanate, in healthy and diabetic rats.
Momir Mikov
2007
Allemand D determination of cantaxantin in the red coral (Corallium rubrum) from marselle by HPLC combined with UV and MS detection.
Momir Mikov
2007
Effect of cholic acid and its keto derivatives on the analgesic action of lidocaine and associated biochemical parameters in rats.
Momir Mikov
2007
Anthracycline-based combined chemotherapy in the mouse model.
Momir Mikov
2007
Determination of critical micellar concentrations of cholic acid and its keto derivatives.
Momir Mikov
2007
Sulfasalazine-old drug, new tricks.
Momir Mikov
2006
Effect of rat pretreatment with aqueous solutions of stevioside and bile acids on the action of certain cardioactive drugs.
Momir Mikov
2006
The influence of probiotic treatment on sulfasalazine metabolism in rat gut contents.
Momir Mikov
2006
Spline functions in convolutional modeling of verapamil bioavailability and bioequivalence. II: Study in healthy volunteers.
Momir Mikov
2006
Chemistry, biosynthesis, analysis, chemical and metabolic transformations and pharmacology.
Momir Mikov
2006
2006
2006
Isolation and determination of bile acids.
Momir Mikov
2006
Chemical and metabolic transformations of selected bile acids.
Momir Mikov
2006
Pharmacology of bile acids and their derivatives: Absorption promoters and therapeutic agents.
Momir Mikov
2006
Bile acids as absorption promoters.
Momir Mikov
2005
Protection of urogenital tract against infections by probiotics.
Momir Mikov
2005
[Common errors in diagnosis and management of urinary tract infections-microbiological aspects].
Momir Mikov
2005
Influence of the bile salt sodium 3α, 7α-dihydroxy-12-oxo-5β-cholanate on ampicillin pharmacokinetics in rats.
Momir Mikov
2005
Chronic exposure to toluene and xylene vapours and their effects on health of workers in the production of paints and varnishes.
Momir Mikov
2004
The ingluence of bile acid derivatives on the hypnotic effect of pentobarbital in the rat.
Momir Mikov
2004
3alfa,7alfa-dihydroxy-12-oxo-5beta-cholanate as blood-brain barrier permeator.
Momir Mikov
2004
Joint effect of commercial preparations of Stevia rebaudiana Bertoni and sodium monoketocholate on glycemia in mice.
Momir Mikov
2004
Subjective disturbances of the health volunteers after acute intake of higher therapeutical dosages of the carbamazepine.
Momir Mikov
2003
The influence of bile acid derivatives on analgesic effect of morphine in rat.
Momir Mikov
2003
New trends in therapeutic application of bile acids.
Momir Mikov
2003
Good clinical Practice with good laboratory practice-development owerview.
Momir Mikov
2002
The future of therapeutic use of bile acids.
Momir Mikov
2002
The influence of sodium salt of monoketocholic acid on quinine transport into the central nervous system in rats.
Momir Mikov
2001
The influence of sodium monoketocholate on ciclosporine induced functional disturbances of rat liver and kidney.
Momir Mikov
2000
Influence of 3 alfa, 7 alfa dihydroxy-12oxo-5beta cholanate on blood glucose levels in rats.
Momir Mikov
2000
The influence of herbicide 2,4-dichlorphenoxyacetic acid on caffeine metabolism and urinary concentration of thioethers in mice.
Momir Mikov
2000
Increased urinary excretion of thioethers as a marker for detecting exposure to herbicide containing 2, 4-dichlorophenoxyacetic acid dimethylamine-experimental study on mice.
Momir Mikov
2000
Effect of simultaneous exposure to benzene and ethanol on urinary phenol excretion in mice.
Momir Mikov
2000
The influence of doxorubicin and N-acetylcysteine on caffeine metabolism in mice.
Momir Mikov
1999
The effect of paracetamol on peritoneal reflex after single and multiple grapefruit ingestion.
Momir Mikov
1999
The influence of anesthetic concentrations of enflurane and ethanol on caffeine metabolism in mice.
Momir Mikov
1999
The role of intestinal microflora in the formation of the methylthio adduct metabolites of paracetamol.
Momir Mikov
1998
Professional and social responsibilities of clinical pharmacology.
Momir Mikov
1997
Gut microflora and verapamil metabolism.
Momir Mikov
1996
Gut microglora and its contribution to formation of methylthio metabolites of paracetamol.
Momir Mikov
1996
Benzene-ethanol interaction and hepatotoxicity.
Momir Mikov
1995
Effeect of N-acetylcysteine on cocaine toxicity.
Momir Mikov
1995
Effect of linum usitatissimum L. on some biochemical parameters of rat liver function.
Momir Mikov
1995
Gut microflora metabolic activity.
Momir Mikov
1995
Paracetamol-3-cysteine acetylation in mice.
Momir Mikov
1995
Pharmacokinetics of carbamazepine derived from a new tablet formulation.
Momir Mikov
1995
Metabolism and toxicity of paracetamol thiometabolites-the origin and fate of 3-methylthio paracetamol.
Momir Mikov
1994
Single and combined efect of phenobarbitone and purine drugs on some biochemical parameters of rat liver.
Momir Mikov
1994
1994
Pharmacokinetic analysis of a new acenocoumarol tablet formulation during a bioequivalence study.
Momir Mikov
1994
Availability and metabolism of paracetamol administered in the form of tablets or suppositories to healthy volunteers.
Momir Mikov
1993
The effect of the radish (Raphanus sativus ssp niger) juice on liver function.
Momir Mikov
1993
Adverse reactions of drugs: 25 years of WHO and 20 years in Yugoslavia.
Momir Mikov
1992
Adverse effect spontaneous reporting and FR Yugoslavia.
Momir Mikov
1992
Adverse effects of drugs reported to regional centre Novi sad 1980-1990.
Momir Mikov
1992
The prevention of paracetamol toxicity by caffeine in mice.
Momir Mikov
1992
Pharmacokinetics of ticlopidine derived from a new tablet formulation.
Momir Mikov
1992
1992
Morbidity of workers exposed to organic solvents in varnish industry.
Momir Mikov
1991
The influence of air pollution with organic solvents on exposed workers health status.
Momir Mikov
1989
Influence of changing life styles and working conditions on the health status of agricultural workers.
Momir Mikov
1989
Acetylsalicylic acid in preeclampsia prevention.
Momir Mikov
1988
Smoking and carboxyhaemoglobin concentrations in mothers and their newborn infants.
Momir Mikov
1986
Metabolic consequences of dichlorvos pretreatment in mice.
Momir Mikov
1985
Poisonings in agriculture.
Momir Mikov
1985
Hearing loss in forest workers-motor saw operators.
Momir Mikov
1982